CGIM
CLPT icon

Cannon Global Investment Management’s ClearPoint Neuro CLPT Stock Holding History

Cannon Global Investment Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,000
Closed -$143K – 83
2025
Q1 		$143K Buy
+12,000
New +$187K 0.25% 67

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Cannon Global Investment Management's CLPT Position: Q2 2025 in Review

Cannon Global Investment Management sold out of ClearPoint Neuro (CLPT) in Q2 2025, closing a stake of 12,000 shares — an estimated $143K sold.

Cannon Global Investment Management first reported a position in CLPT in Q1 2025 and held it in 1 quarter. The position peaked at $143K in Q1 2025. 96 funds tracked by Wall St. Rank hold CLPT as of Q2 2025.

  • Cannon Global Investment Management reported no remaining ClearPoint Neuro position as of Q2 2025 after selling out during the quarter.
  • Cannon Global Investment Management sold 12,000 ClearPoint Neuro shares in Q2 2025, an estimated $143K.
  • Cannon Global Investment Management first reported a position in ClearPoint Neuro in Q1 2025 and held it in 1 quarter.
  • Cannon Global Investment Management's ClearPoint Neuro position peaked at $143K in Q1 2025.
  • 96 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2025.

Based on Cannon Global Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.